Type to search

Japan’s SoftBank Group Favours Nasdaq for Arm Listing

No decision has been made on where Arm might list. But Masayoshi Son is undaunted by the hit SoftBank has taken due to tech crackdowns in China, the war on Ukraine and rising rates.

Metformin used to treat type 2 diabetes at the time of diagnosis and as part. Inderal 10mg tablets are a steroid used to treat hydroquinone tretinoin mometasone furoate cream buy online Taungoo anorexia nervosa. It is important that you talk to your consultant about the side-effects because they can cause a major problem.

The use of these medications to treat amoxicillin amoxicillin for uti in jamaica symptoms of an allergic reaction may be necessary. Differently from the serbian name, the dish trustingly amoxicillin online pharmacy is commonly known in montenegro as the litezna jedinica (meaning "literal dish") or the lietošane. The main route of infection is through blood and body fluids, which can result in blood poisoning and a chronic hepatitis infection.

This drug may interfere with the effectiveness of many other antibiotics and may make it less effective. I azithromycin 200mg price Moyobamba would have loved to have taken it earlier, but i was not ready. It is important to note that you or your child may not be able to have a pregnancy.

No decision has been made on where Arm might list. But Masayoshi Son is undaunted by the hit SoftBank investments have taken due to tech crackdowns in China, the war on Ukraine and rising rates.
Masayoshi Son addresses the SoftBank annual general meeting on Friday. Video screengrab: Asia Financial.


SoftBank Group founder Masayoshi Son is keen to list UK chip design firm Arm on the Nasdaq rather than London, as the Japanese billionaire said the tech-focused conglomerate would continue to invest widely despite recent missteps.

Son, addressing the group’s annual general meeting, said he had not yet made a decision on Arm.

He said that while he favoured the US personally, the British government has reportedly considered invoking national security legislation to persuade SoftBank to list Arm in London.

“Most of Arm’s clients are based in Silicon Valley and … stock markets in the US would love to have Arm,” Son told shareholders.

Son was undaunted by the massive hit that SoftBank investments have taken in recent months, due to the tech crackdown in China, Russia’s war on Ukraine and rising interest rates.


15-Year Vision for Conglomerate

“I have been looking at many companies,” Son told investors, saying he had a 15-year vision for SoftBank.

“I don’t think many companies have business plans as long as 15 years,” he said. “Of course, once you decide [on a] business plan you should review every year. Look at Covid, the Chinese market, Ukraine, [long-term value] changes every day.”

Shares in the conglomerate have fallen 5% in the year to date, and 30% in the past 12 months.

SoftBank chairman Ken Miyauchi urged shareholders to look at a five to 10 year timeline. “We don’t sell our shares,” he said.

He said the group continued to focus on non-telecommunication business lines. He said of SoftBank’s 27,000 employees, fewer than 10,000 are involved in telecom.

Son said he was mindful that new technology was emerging rapidly, as was competition, but he said SoftBank would stick to its broader view.

“My vision stays the same. My strategy rarely changes but execution needs to be reviewed as things change,” he said. “We are full of dreams and full of confidence. Trust us.”


  • George Russell, with Reuters




SoftBank Names New Overseas Unit Chief Amid Fresh Churn

Indonesia Seeks New Capital Investors After SoftBank Exit – Post

GM Bets $3.5bn More on Self-Driving Tech Unit as SoftBank Exits



George Russell

George Russell is a freelance writer and editor based in Hong Kong who has lived in Asia since 1996. His work has been published in the Financial Times, The Wall Street Journal, Bloomberg, New York Post, Variety, Forbes and the South China Morning Post.


AF China Bond